Lumiata Closes $10 Million Series B Financing with Intel Capital to Advance Medical Artificial Intelligence for Healthcare

Lumiata, the AI-powered predictive analytics company, today announced that it has raised $10 million in financing led by Intel Capital. This latest announcement comes as Lumiata accelerates its deployment of medical artificial intelligence that dramatically improves risk and care management for payers, physicians and population health organizations.All existing investors, including Blue Cross Blue Shield Venture Partners, Sandbox Industries, and Khosla Ventures fully participated in this Series B Round.The latest round of funding brings the total amount of capital raised by Lumiata to $20 million.